CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

PUREGENE AG has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 Genomics Solutions Companies in Europe/UK – 2022,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with , .

PUREGENE AG
Farming the Future with Trait-Based Cannabis

PUREGENE AG

Dr. Gavin George, Co-Founder and CEO, PUREGENE AGDr. Gavin George, Co-Founder and CEO
Recent scientific breakthroughs in the world of cannabis have driven farmers to cultivate the plant for more than the market’s recreational and pharmaceutical needs. Cosmetic, construction, and automobile industries have found applications for the plant as a sustainable resource. Recent developments have led to a sharp increase in demand, compelling farmers to seek cutting-edge breeding processes and agriculture technology to produce economical and high-quality yields. However, the harvest may lack the cost effectiveness or qualities that benefit the unique requirements of these industries. Puregene, a Swiss based plant breeding company, assists farmers and businesses in utilizing the plant for various purposes via trait based cannabis breeding.

Puregene leverages data-driven molecular breeding processes borne of extensive genome research to develop several varieties of cannabis according to each client’s specific needs. The company’s highly-trained researchers employ genomic and phenotypic data that studies the productivity, chemical makeup, and stability of cannabis for application in medicinal and industrial settings. Through the many insights and results obtained with the cannabis industry’s first-ever pan genomic reference sequence, the biotech company created 350 traits that are applied to the breeding process. The common data set is stacked in Puregene’s artificial intelligence (AI) and machine learning (ML) algorithms to become building blocks of the process. These technological tools aid researchers in reassembling the cannabis DNA genome, producing trait-specific plant varieties.

The genomic prediction algorithms designed by Puregene’s seasoned bioinformaticians can predict the performance of newly cultivated strains of the plant, granting access to a richer data set to reference.

The biotech company’s researchers can then increase their efficiency in resequencing cannabis traits, ensuring that the created variety delivers the desired results.

“To develop products using cannabis, today’s businesses demand stability in its harvesting. This is made possible with our molecular breeding processes, transforming the plant’s global landscape and boosting economies everywhere,” says Dr. Gavin George, Cofounder and CEO of Puregene AG.

The company has worked with Swiss and Canadian farmers, a Mexican cosmetic brand, and an automobile enterprise to create cannabis varieties with specified levels of THC that also suit their respective environments. Practicing industry gold standard phytosanitary techniques to maintain healthy plants, Puregene assures the highest standards of varieties through its quality control system.

To develop products using cannabis, today’s businesses demand stability in its harvesting. This is made possible with our molecular breeding processes, transforming the plant’s global landscape and boosting economies everywhere

There is no limit to the number of variants that can be developed when working with genomics. Puregene’s ML algorithms have enabled predictive breeding, making it easier and faster to implement the breeding program and cultivate new strains.

Proving Puregene’s expertise in developing trait-specific cannabis, Dr. George shares the story of how it helped a local Swiss farmer by creating a new variety as per their requirements. The client wanted to cultivate a variant for the low-THC market in collaboration with its sister company. However, the quality harvest failed to generate the expected revenue. After Puregene analyzed the situation, the biotech company employed its molecular breeding processes and ML algorithms to develop a new strain of cannabis that performed better, resulting in a 60 percent increase in the new yield’s final sale price.

Puregene ensures that championing cannabis and its utilization as an environmentally friendly alternative will bring great benefits to many industries, and the ecology at large. Through its revolutionary plant breeding processes, the biotech company aims to help positively impact agriculture technology advancement on a global scale.

Top 10 Genomics Solutions Companies in Europe/UK – 2022
Current Issue

Company : PUREGENE AG

Management
Dr. Gavin George, Co-Founder and CEO

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/puregene-ag